Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report

Table 1 Summary of TSI administration, pulmonary status, and hematologic profiles before 5 years

	Before TSI Therapy	TSI started 150 mg/2.5 mL twice daily	On TSI 150 mg/2.5 mL twice daily	TSI Increased to 300 mg/5 mL twice daily	On TSI 300 mg/5 mL twice daily
Age	6 months	16 months	2 years	2 1/2 years	4 years
Pulmonary Status	No wheezing	(+) wheezing; 1^st (+) throat culture for P. aeruginosa	(+) wheezing	(+) wheezing	(+) wheezing
WBC (/mm ³ )	15.2	NA	9.1	12	11.2
Eosinophils (%)	1	NA	11	15	20
IgE (IU/mL)	NA	NA	843	NA	299

Abbreviations: TSI, tobramycin solution for inhalation; WBC, white blood cell count; NA, not available

ISSN: 1471-2431